Design and Optimization of New Enteric Nanoparticles of Ceftriaxone for Oral Delivery: In vitro and in vivo Assessments
Amir Maghrabia,1 Mariza Boughdady,2 Mahasen Meshali2 1Department of Pharmacy, Urology and Nephrology Center, Mansoura University, Mansoura, 35516, Egypt; 2Department of Pharmaceutics, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, EgyptCorrespondence: Amir MaghrabiaDepartment of Pharmacy...
Guardado en:
Autores principales: | Maghrabia A, Boughdady M, Meshali M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c3c682a4ac164e73bad20284c0e0a6ff |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ceftriaxone treatment of syphilis
por: Georgiy L. Katunin, et al.
Publicado: (2021) -
CHEMICAL STABILITY OF CEFTRIAXONE BY A VALIDATED STABILITY-INDICATING LIQUID CHROMATOGRAPHIC METHOD
por: DE DIEGO,M, et al.
Publicado: (2010) -
Ceftriaxone-induced Encephalopathy: A Pharmacokinetic Approach
por: Laurent Jadot, et al.
Publicado: (2021) -
SIMULTANEOUS DETERMINATION OF CEFTRIAXONE SODIUM AND STATIN DRUGS IN PHARMACEUTICAL FORMULATIONS AND HUMAN SERUM BY RP-HPLC
por: SULTANA,NAJMA, et al.
Publicado: (2010) -
Ceftriaxone Mediated Synthesized Gold Nanoparticles: A Nano-Therapeutic Tool to Target Bacterial Resistance
por: Farhan Alshammari, et al.
Publicado: (2021)